Navigation Links
Johns Hopkins researchers detect sweet cacophony while listening to cellular cross-talk
Date:10/20/2008

Johns Hopkins scientists were dubious in the early 1980s when they stumbled on small sugar molecules lurking in the centers of cells; not only were they not supposed to be there, but they certainly weren't supposed to be repeatedly attaching to and detaching from proteins, effectively switching them on and off. The conventional wisdom was that the job of turning proteins on and off -- and thus determining their actions -- fell to phosphates, in a common and easy-to-detect chemical step in which phosphates fasten to and unfasten from proteins; a process called phosphorylation.

Now, after decades of investigating the "new" sugar-based protein modification they discovered, the Johns Hopkins team admits that they themselves were surprised by their latest results. Published recently in the Proceedings of the National Academy of Sciences, their findings show that the surreptitious sugar switch is likely as influential and ubiquitous as its phosphate counterpart and, indeed, even plays a role in regulating phosphorylation itself.

More to the point, the work has implications for finding new treatments for a number of diseases such as diabetes, neurodegeneration and cancer, because the new switches form yet another potential target for manipulation by drugs.

"Like dark matter in the cosmos, it's hard to find even though it's very abundant," says Gerald Hart, Ph.D., the DeLamar Professor and director of biological chemistry at the Johns Hopkins School of Medicine, referring to the sugar (O-GlcNAc, pronounced oh-GLICK-nac) that carries out GlcNAcylation.

For years, Hart's team thought of GlcNAcylation as phosphorylation's foil; a simple, classic case of either-or. New technologies involving molecular sleuthing with a mass spectrometer allowed them to measure the extent to which the addition of sugar to proteins affects phosphorylation.

Of 428 sites on which phosphate was being added to and taken off of proteins, all responded in some way to increased O-GlcNAc: 280 decreased phosphorylation and 148 increased phosphorylation.

"The influence of sugar is striking," Hart says. "The presence of O-GlcNAc causes the enzymes that add the phosphate to do something different, and this cross-talk itself can modify proteins."

Because both sugar and phosphate modifications are linked to how cells work, they are fundamental to understanding and eventual control of the molecular processes that underlie many diseases.

"With regard to cancer, diabetes and Alzheimer's," says Hart, "most people in the world today have been studying the yang (phosphorylation) but not the yin (GlcNAcylation). There's another whole side that people were unaware of where diabetes diagnostics and cancer therapies could be targeted."


'/>"/>

Contact: Maryalice Yakutchik
myakutc1@jhmi.edu
443-287-2251
Johns Hopkins Medical Institutions
Source:Eurekalert

Related biology news :

1. Grant to fund answers about St. Johns River
2. Johns Hopkins scientists discover what drives the development of a fatal form of malaria
3. Johnson & Johnson honors 2008 recipients of the Dr. Paul Janssen Award for Biomedical Research
4. Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
5. Worth a thousand words: Hopkins researchers paint picture of cancer-promoting culprit
6. Hopkins researchers piece together gene network linked to schizophrenia
7. Researchers identify proteins involved in new neurodegenerative syndrome
8. Texas researchers and educators head for Antarctica
9. MGH researchers describe new way to identify, evolve novel enzymes
10. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
11. U of MN researchers discover noninvasive diagnostic tool for brain diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... (PRWEB) , ... December 02, ... ... (ETC), a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing ... companies interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... 30, 2016  GenomOncology today announced the appointment of ... Affairs.  Dr. Coleman will oversee clinical content ... knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with ... and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... 2016 Biotest Pharmaceuticals Corporation (BPC), a leading ... the addition of its newest plasma collection center located ... . The 15,200 square foot state-of-the-art facility officially opened ... brings the total number of BPC,s plasma collection centers ... BPC,s Chief Executive Officer said "We are pleased to ...
Breaking Biology Technology: